| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,804 |
4,529 |
$712K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,510 |
3,825 |
$695K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,095 |
3,141 |
$577K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,551 |
301 |
$301K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,224 |
740 |
$269K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,044 |
1,737 |
$264K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
877 |
766 |
$212K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
572 |
441 |
$209K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,340 |
1,171 |
$69K |
| 70450 |
Computed tomography, head or brain; without contrast material |
246 |
197 |
$54K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,724 |
3,025 |
$35K |
| G0378 |
Hospital observation service, per hour |
441 |
279 |
$19K |
| 85027 |
|
4,161 |
3,437 |
$16K |
| 80053 |
Comprehensive metabolic panel |
2,051 |
1,646 |
$15K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
789 |
244 |
$14K |
| 81025 |
|
1,306 |
1,136 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,059 |
924 |
$12K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
569 |
491 |
$12K |
| 81001 |
|
2,978 |
2,536 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,992 |
1,519 |
$10K |
| 84484 |
|
1,647 |
1,225 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,725 |
2,202 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
84 |
74 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
1,227 |
1,090 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
144 |
138 |
$5K |
| 82248 |
|
1,734 |
1,379 |
$4K |
| 83690 |
|
824 |
699 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
490 |
396 |
$3K |
| 84702 |
|
214 |
151 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
17 |
12 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,598 |
2,089 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
142 |
117 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,996 |
4,653 |
$2K |
| 80076 |
|
322 |
242 |
$2K |
| 0012A |
|
60 |
54 |
$2K |
| 0011A |
|
96 |
91 |
$2K |
| 83735 |
|
413 |
327 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
238 |
214 |
$1K |
| 83605 |
|
236 |
159 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,880 |
2,011 |
$908.82 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,732 |
1,453 |
$857.96 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
71 |
67 |
$756.19 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,834 |
2,511 |
$733.44 |
| 0240U |
|
45 |
37 |
$608.56 |
| 85610 |
|
206 |
144 |
$600.87 |
| 84443 |
Thyroid stimulating hormone (TSH) |
65 |
53 |
$576.28 |
| 85379 |
|
110 |
88 |
$573.87 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$507.20 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,451 |
1,197 |
$451.21 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$393.18 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,498 |
1,823 |
$363.37 |
| 82947 |
|
89 |
67 |
$300.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,865 |
1,526 |
$284.90 |
| 71045 |
Radiologic examination, chest; single view |
454 |
382 |
$284.82 |
| 82077 |
|
26 |
24 |
$248.76 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,304 |
873 |
$236.32 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
113 |
72 |
$207.89 |
| 86140 |
|
70 |
55 |
$194.69 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,143 |
1,485 |
$180.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,708 |
1,109 |
$172.21 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$168.60 |
| 87040 |
|
44 |
24 |
$159.90 |
| 82962 |
|
44 |
25 |
$112.40 |
| 81003 |
|
18 |
13 |
$82.92 |
| 86901 |
|
15 |
12 |
$55.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
262 |
178 |
$44.69 |
| 99152 |
|
17 |
14 |
$2.75 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
17 |
14 |
$1.79 |
| A9270 |
Non-covered item or service |
2,959 |
1,235 |
$0.14 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,089 |
937 |
$0.03 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
18 |
13 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
118 |
67 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
35 |
27 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
15 |
$0.00 |